Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

The Washing Machine as a Reservoir for Transmission of Extended-Spectrum-Beta-Lactamase (CTX-M-15)-Producing Klebsiella oxytoca ST201 to Newborns.

Schmithausen RM, Sib E, Exner M, Hack S, Rösing C, Ciorba P, Bierbaum G, Savin M, Bloomfield SF, Kaase M, Jacobshagen A, Gemein S, Gebel J, Engelhart S, Exner D.

Appl Environ Microbiol. 2019 Oct 30;85(22). pii: e01435-19. doi: 10.1128/AEM.01435-19. Print 2019 Nov 15.

2.

Early Detection of Infection Chains & Outbreaks: Use Case Infection Control.

Sargeant A, von Landesberger T, Baier C, Bange F, Dalpke A, Eckmanns T, Glöckner S, Kaase M, Krause G, Marschollek M, Malone B, Niepert M, Rey S, Wulff A; Consortium H, Scheithauer S.

Stud Health Technol Inform. 2019;258:245-246.

PMID:
30942759
3.

Overestimation of an Outbreak of Enterobacter cloacae in a Neonatal Intensive Care Unit in Germany, 2015.

Steffen G, Pietsch M, Kaase M, Gatermann S, Werner G, Fuchs S, Pfeifer Y, Schmitt W, Adam H, Eckmanns T, Haller S.

Pediatr Infect Dis J. 2019 Jun;38(6):631-637. doi: 10.1097/INF.0000000000002264.

PMID:
30550512
4.

Characterization of mutations in Escherichia coli PBP2 leading to increased carbapenem MICs.

Lange F, Pfennigwerth N, Höfken LM, Gatermann SG, Kaase M.

J Antimicrob Chemother. 2019 Mar 1;74(3):571-576. doi: 10.1093/jac/dky476.

PMID:
30496417
5.

LMB-1, a novel family of class B3 MBLs from an isolate of Enterobacter cloacae.

Lange F, Pfennigwerth N, Hartl R, Kerschner H, Achleitner D, Gatermann SG, Kaase M.

J Antimicrob Chemother. 2018 Sep 1;73(9):2331-2335. doi: 10.1093/jac/dky215.

PMID:
29897538
6.

Transmission Risk on a Neonatal Intensive Care Unit: Escherichia coli versus Klebsiella pneumoniae.

Artelt T, Kaase M, Bley I, Eiffert H, Mellmann A, Küster H, Lange M, Scheithauer S.

Can J Infect Dis Med Microbiol. 2018 Apr 29;2018:1525072. doi: 10.1155/2018/1525072. eCollection 2018.

7.

Genome-based analysis of Carbapenemase-producing Klebsiella pneumoniae isolates from German hospital patients, 2008-2014.

Becker L, Kaase M, Pfeifer Y, Fuchs S, Reuss A, von Laer A, Sin MA, Korte-Berwanger M, Gatermann S, Werner G.

Antimicrob Resist Infect Control. 2018 May 2;7:62. doi: 10.1186/s13756-018-0352-y. eCollection 2018.

8.

[Prevention and Detection of Multidrug-resistant Bacteria].

Scheithauer S, Kaase M.

Dtsch Med Wochenschr. 2018 May;143(9):634-642. doi: 10.1055/s-0043-115622. Epub 2018 Apr 23. German.

PMID:
29684930
9.

[Effective management of an outbreak with multiresistent Klebsiella pneumoniae in a neurorehabilitation unit].

Dohle C, Korr G, Friedrichs M, Kullmann V, Tung ML, Kaase M, Rüssmann H, Sissolak D, Werber D, Becker L, Fuchs S, Pfeifer Y, Semmler T, Widders G, Eckmanns T, Werner G, Zill E, Haller S.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018 May;61(5):543-552. doi: 10.1007/s00103-018-2728-9. Review. German.

PMID:
29633038
10.

Whole Genome Sequence Analysis of CTX-M-15 Producing Klebsiella Isolates Allowed Dissecting a Polyclonal Outbreak Scenario.

Becker L, Fuchs S, Pfeifer Y, Semmler T, Eckmanns T, Korr G, Sissolak D, Friedrichs M, Zill E, Tung ML, Dohle C, Kaase M, Gatermann S, Rüssmann H, Steglich M, Haller S, Werner G.

Front Microbiol. 2018 Feb 23;9:322. doi: 10.3389/fmicb.2018.00322. eCollection 2018.

11.

Stalking a lethal superbug by whole-genome sequencing and phylogenetics: Influence on unraveling a major hospital outbreak of carbapenem-resistant Klebsiella pneumoniae.

Kaiser T, Finstermeier K, Häntzsch M, Faucheux S, Kaase M, Eckmanns T, Bercker S, Kaisers UX, Lippmann N, Rodloff AC, Thiery J, Lübbert C.

Am J Infect Control. 2018 Jan;46(1):54-59. doi: 10.1016/j.ajic.2017.07.022. Epub 2017 Sep 19.

PMID:
28935481
12.

Comparison of in-house and commercial real time-PCR based carbapenemase gene detection methods in Enterobacteriaceae and non-fermenting gram-negative bacterial isolates.

Smiljanic M, Kaase M, Ahmad-Nejad P, Ghebremedhin B.

Ann Clin Microbiol Antimicrob. 2017 Jul 10;16(1):48. doi: 10.1186/s12941-017-0223-z.

13.

Genome Analysis of the Carbapenem- and Colistin-Resistant Escherichia coli Isolate NRZ14408 Reveals Horizontal Gene Transfer Pathways towards Panresistance and Enhanced Virulence.

Falgenhauer L, Ghosh H, Doijad S, Yao Y, Bunk B, Spröer C, Kaase M, Hilker R, Overmann J, Imirzalioglu C, Chakraborty T.

Antimicrob Agents Chemother. 2017 Mar 24;61(4). pii: e02359-16. doi: 10.1128/AAC.02359-16. Print 2017 Apr. No abstract available.

14.

Dissemination of blaOXA-58 in Proteus mirabilis isolates from Germany.

Lange F, Pfennigwerth N, Gerigk S, Gohlke F, Oberdorfer K, Purr I, Wohanka N, Roggenkamp A, Gatermann SG, Kaase M.

J Antimicrob Chemother. 2017 May 1;72(5):1334-1339. doi: 10.1093/jac/dkw566.

PMID:
28093482
15.

Genetic and biochemical characterization of HMB-1, a novel subclass B1 metallo-β-lactamase found in a Pseudomonas aeruginosa clinical isolate.

Pfennigwerth N, Lange F, Belmar Campos C, Hentschke M, Gatermann SG, Kaase M.

J Antimicrob Chemother. 2017 Apr 1;72(4):1068-1073. doi: 10.1093/jac/dkw554.

PMID:
28065891
16.

Comparison of Phenotypic Tests and an Immunochromatographic Assay and Development of a New Algorithm for Detection of OXA-48-like Carbapenemases.

Koroska F, Göttig S, Kaase M, Steinmann J, Gatermann S, Sommer J, Wille T, Plum G, Hamprecht A.

J Clin Microbiol. 2017 Mar;55(3):877-883. doi: 10.1128/JCM.01929-16. Epub 2016 Dec 28.

17.

Protracted Regional Dissemination of GIM-1-Producing Serratia marcescens in Western Germany.

Wendel AF, Kaase M, Autenrieth IB, Peter S, Oberhettinger P, Rieber H, Pfeffer K, MacKenzie CR, Willmann M.

Antimicrob Agents Chemother. 2017 Feb 23;61(3). pii: e01880-16. doi: 10.1128/AAC.01880-16. Print 2017 Mar.

18.

First report of Escherichia coli co-producing NDM-1 and OXA-232.

Both A, Huang J, Kaase M, Hezel J, Wertheimer D, Fenner I, Günther T, Grundhoff A, Büttner H, Aepfelbacher M, Rohde H, Hentschke M.

Diagn Microbiol Infect Dis. 2016 Dec;86(4):437-438. doi: 10.1016/j.diagmicrobio.2016.09.005. Epub 2016 Sep 16.

PMID:
27681362
19.

Carbapenem-resistant Gram-negative bacteria - analysis of the data obtained through a mandatory reporting system in the Rhine-Main region, Germany, 2012-2015.

Heudorf U, Büttner B, Hauri AM, Heinmüller P, Hunfeld KP, Kaase M, Kleinkauf N, Albert-Braun S, Tessmann R, Kempf VA.

GMS Hyg Infect Control. 2016 Apr 28;11:Doc10. doi: 10.3205/dgkh000270. eCollection 2016.

20.

Multicentre investigation of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in German hospitals.

Kaase M, Schimanski S, Schiller R, Beyreiß B, Thürmer A, Steinmann J, Kempf VA, Hess C, Sobottka I, Fenner I, Ziesing S, Burckhardt I, von Müller L, Hamprecht A, Tammer I, Wantia N, Becker K, Holzmann T, Furitsch M, Volmer G, Gatermann SG.

Int J Med Microbiol. 2016 Sep;306(6):415-20. doi: 10.1016/j.ijmm.2016.05.009. Epub 2016 May 13.

PMID:
27237423
21.

False non-susceptible results of tigecycline susceptibility testing against Enterobacteriaceae by an automated system: a multicentre study.

Idelevich EA, Büsing M, Mischnik A, Kaase M, Bekeredjian-Ding I, Becker K.

J Med Microbiol. 2016 Aug;65(8):877-881. doi: 10.1099/jmm.0.000281. Epub 2016 May 17. No abstract available.

PMID:
27188162
22.

MALDI-TOF MS based carbapenemase detection from culture isolates and from positive blood culture vials.

Ghebremedhin B, Halstenbach A, Smiljanic M, Kaase M, Ahmad-Nejad P.

Ann Clin Microbiol Antimicrob. 2016 Feb 2;15:5. doi: 10.1186/s12941-016-0120-x.

23.

Community-acquired adult Escherichia coli meningitis leading to diagnosis of unrecognized retropharyngeal abscess and cervical spondylodiscitis: a case report.

Kohlmann R, Nefedev A, Kaase M, Gatermann SG.

BMC Infect Dis. 2015 Dec 12;15:567. doi: 10.1186/s12879-015-1310-4.

24.

Activity of temocillin, mecillinam, ceftazidime, and ceftazidime/avibactam against carbapenem-non-susceptible Enterobacteriaceae without carbapenemase production.

Mutters NT, Zimmermann S, Kaase M, Mischnik A.

Eur J Clin Microbiol Infect Dis. 2015 Dec;34(12):2429-37. doi: 10.1007/s10096-015-2498-3. Epub 2015 Oct 3.

PMID:
26433746
25.

Molecular epidemiology of VIM-1 producing Escherichia coli from Germany referred to the National Reference Laboratory.

Kaase M, Pfennigwerth N, Lange F, Anders A, Gatermann SG.

Int J Med Microbiol. 2015 Oct;305(7):784-9. doi: 10.1016/j.ijmm.2015.08.032. Epub 2015 Aug 22.

PMID:
26321009
26.

What caused the outbreak of ESBL-producing Klebsiella pneumoniae in a neonatal intensive care unit, Germany 2009 to 2012? Reconstructing transmission with epidemiological analysis and whole-genome sequencing.

Haller S, Eller C, Hermes J, Kaase M, Steglich M, Radonić A, Dabrowski PW, Nitsche A, Pfeifer Y, Werner G, Wunderle W, Velasco E, Abu Sin M, Eckmanns T, Nübel U.

BMJ Open. 2015 May 11;5(5):e007397. doi: 10.1136/bmjopen-2014-007397.

27.

Description of IMP-31, a novel metallo-β-lactamase found in an ST235 Pseudomonas aeruginosa strain in Western Germany.

Pfennigwerth N, Geis G, Gatermann SG, Kaase M.

J Antimicrob Chemother. 2015 Jul;70(7):1973-80. doi: 10.1093/jac/dkv079. Epub 2015 Apr 2.

PMID:
25835992
28.

An outbreak of carbapenem-resistant OXA-48 - producing Klebsiella pneumonia associated to duodenoscopy.

Kola A, Piening B, Pape UF, Veltzke-Schlieker W, Kaase M, Geffers C, Wiedenmann B, Gastmeier P.

Antimicrob Resist Infect Control. 2015 Mar 25;4:8. doi: 10.1186/s13756-015-0049-4. eCollection 2015.

29.

Cross-border comparison of the Dutch and German guidelines on multidrug-resistant Gram-negative microorganisms.

Müller J, Voss A, Köck R, Sinha B, Rossen JW, Kaase M, Mielke M, Daniels-Haardt I, Jurke A, Hendrix R, Kluytmans JA, Kluytmans-van den Bergh MF, Pulz M, Herrmann J, Kern WV, Wendt C, Friedrich AW.

Antimicrob Resist Infect Control. 2015 Feb 27;4:7. doi: 10.1186/s13756-015-0047-6. eCollection 2015.

30.

[Carbapenem-resistance in Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter baumannii].

Mischnik A, Kaase M, Lübbert C, Seifert H, Kern WV.

Dtsch Med Wochenschr. 2015 Feb;140(3):172-6. doi: 10.1055/s-0041-100105. Epub 2015 Feb 6. Review. German. No abstract available.

PMID:
25658402
31.

Molecular characterization of carbapenemase production among gram-negative bacteria in saudi arabia.

Memish ZA, Assiri A, Almasri M, Roshdy H, Hathout H, Kaase M, Gatermann SG, Yezli S.

Microb Drug Resist. 2015 Jun;21(3):307-14. doi: 10.1089/mdr.2014.0121. Epub 2015 Jan 8.

PMID:
25569024
32.

Development and evaluation of a novel universal β-lactamase gene subtyping assay for blaSHV, blaTEM and blaCTX-M using clinical and livestock-associated Escherichia coli.

Strauß LM, Dahms C, Becker K, Kramer A, Kaase M, Mellmann A.

J Antimicrob Chemother. 2015 Mar;70(3):710-5. doi: 10.1093/jac/dku450. Epub 2014 Nov 20.

PMID:
25414200
33.

Complete Nucleotide Sequence of a Citrobacter freundii Plasmid Carrying KPC-2 in a Unique Genetic Environment.

Yao Y, Imirzalioglu C, Hain T, Kaase M, Gatermann S, Exner M, Mielke M, Hauri A, Dragneva Y, Bill R, Wendt C, Wirtz A, Domann E, Chakraborty T.

Genome Announc. 2014 Nov 13;2(6). pii: e01157-14. doi: 10.1128/genomeA.01157-14.

34.

Emergence of Citrobacter freundii carrying IMP-8 metallo-β-lactamase in Germany.

Peter S, Wolz C, Kaase M, Marschal M, Schulte B, Vogel W, Autenrieth I, Willmann M.

New Microbes New Infect. 2014 Mar;2(2):42-5. doi: 10.1002/nmi2.36. Epub 2014 Mar 20.

35.

A pseudo-outbreak due to Acinetobacter species (GIM-1) contamination of the pneumatic transport system of a Large University Hospital.

Herrmann M, Jungmann S, Halfmann A, Dawson A, Kaase M, Gatermann S, von Müller L, Gärtner BC.

Infect Control Hosp Epidemiol. 2014 Nov;35(11):1364-72. doi: 10.1086/678413. Epub 2014 Sep 29.

PMID:
25333431
36.

[Prevalence of carbapenemase-producing bacteria in hospitals in Saxony, Germany].

Ehrhard I, Karaalp AK, Hackel T, Höll G, Rodewald N, Reif U, Kaase M, Eckmanns T, Sydow W.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014 Apr;57(4):406-13. doi: 10.1007/s00103-013-1914-z. German.

PMID:
24658670
37.

Fosfomycin susceptibility in carbapenem-resistant Enterobacteriaceae from Germany.

Kaase M, Szabados F, Anders A, Gatermann SG.

J Clin Microbiol. 2014 Jun;52(6):1893-7. doi: 10.1128/JCM.03484-13. Epub 2014 Mar 19. Erratum in: J Clin Microbiol. 2014 Aug;52(8):3135.

38.

Detection of carbapenemases by real-time PCR and melt curve analysis on the BD Max system.

Hofko M, Mischnik A, Kaase M, Zimmermann S, Dalpke AH.

J Clin Microbiol. 2014 May;52(5):1701-4. doi: 10.1128/JCM.00373-14. Epub 2014 Feb 12.

39.

Evaluation of phenotypic detection methods for metallo-β-lactamases (MBLs) in clinical isolates of Pseudomonas aeruginosa.

Peter S, Lacher A, Marschal M, Hölzl F, Buhl M, Autenrieth I, Kaase M, Willmann M.

Eur J Clin Microbiol Infect Dis. 2014 Jul;33(7):1133-41. doi: 10.1007/s10096-014-2059-1. Epub 2014 Jan 23.

PMID:
24452967
40.

International multicenter evaluation of the DiversiLab bacterial typing system for Escherichia coli and Klebsiella spp.

Voets GM, Leverstein-van Hall MA, Kolbe-Busch S, van der Zanden A, Church D, Kaase M, Grisold A, Upton M, Cloutman-Green E, Cantón R, Friedrich AW, Fluit AC; DiversiLab Study Group.

J Clin Microbiol. 2013 Dec;51(12):3944-9. doi: 10.1128/JCM.01664-13. Epub 2013 Sep 11.

41.

Description of the metallo-β-lactamase GIM-1 in Acinetobacter pittii.

Kaase M, Szabados F, Pfennigwerth N, Anders A, Geis G, Pranada AB, Rößler S, Lang U, Gatermann SG.

J Antimicrob Chemother. 2014 Jan;69(1):81-4. doi: 10.1093/jac/dkt325. Epub 2013 Aug 16.

PMID:
23956376
42.

DNA microarray for genotyping antibiotic resistance determinants in Acinetobacter baumannii clinical isolates.

Dally S, Lemuth K, Kaase M, Rupp S, Knabbe C, Weile J.

Antimicrob Agents Chemother. 2013 Oct;57(10):4761-8. doi: 10.1128/AAC.00863-13. Epub 2013 Jul 15.

43.

Spread of NDM-2-producing Acinetobacter baumannii in the Middle East.

Espinal P, Poirel L, Carmeli Y, Kaase M, Pal T, Nordmann P, Vila J.

J Antimicrob Chemother. 2013 Aug;68(8):1928-30. doi: 10.1093/jac/dkt109. Epub 2013 May 14. No abstract available.

PMID:
23674763
44.

Detection of the carbapenemase GIM-1 in Enterobacter cloacae in Germany.

Hamprecht A, Poirel L, Göttig S, Seifert H, Kaase M, Nordmann P.

J Antimicrob Chemother. 2013 Mar;68(3):558-61. doi: 10.1093/jac/dks447. Epub 2012 Nov 14.

PMID:
23152484
45.

[Carbapenemases in gram-negative bacteria. Current data and trends of resistance resulting from the work of national reference centres].

Kaase M.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2012 Nov;55(11-12):1401-4. doi: 10.1007/s00103-012-1552-x. German.

PMID:
23114438
46.

[What does ESBL mean?].

Kaase M, Kern WV.

Dtsch Med Wochenschr. 2012 Oct;137(40):2010-3. Epub 2012 Sep 28. Review. German. No abstract available.

PMID:
23023611
47.

First description of Escherichia coli producing CTX-M-15- extended spectrum beta lactamase (ESBL) in out-patients from south eastern Nigeria.

Iroha IR, Esimone CO, Neumann S, Marlinghaus L, Korte M, Szabados F, Gatermann S, Kaase M.

Ann Clin Microbiol Antimicrob. 2012 Jul 23;11:19. doi: 10.1186/1476-0711-11-19.

48.

Detection of carbapenemases in Enterobacteriaceae by a commercial multiplex PCR.

Kaase M, Szabados F, Wassill L, Gatermann SG.

J Clin Microbiol. 2012 Sep;50(9):3115-8. doi: 10.1128/JCM.00991-12. Epub 2012 Jul 11.

49.

Identical MALDI TOF MS-derived peak profiles in a pair of isogenic SCCmec-harboring and SCCmec-lacking strains of Staphylococcus aureus.

Szabados F, Kaase M, Anders A, Gatermann SG.

J Infect. 2012 Nov;65(5):400-5. doi: 10.1016/j.jinf.2012.06.010. Epub 2012 Jun 28.

PMID:
22750235
50.

Evaluation of species-specific score cut-off values for various Staphylococcus species using a MALDI Biotyper-based identification.

Richter C, Hollstein S, Woloszyn J, Kaase M, Gatermann SG, Szabados F.

J Med Microbiol. 2012 Oct;61(Pt 10):1409-16. doi: 10.1099/jmm.0.042606-0. Epub 2012 Jun 28.

PMID:
22745134

Supplemental Content

Support Center